AIP
CAMP icon

Ameritas Investment Partners’s CAMP4 Therapeutics CAMP Stock Holding History

Ameritas Investment Partners’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-720
Closed -$2.88K – 3220
2025
Q1 		$2.88K Hold
720
– – ﹤0.01% 3048
2024
Q4 		$3.76K Buy
+720
New +$5.92K ﹤0.01% 3060

Other funds holding CAMP

ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameritas Investment Partners's CAMP Position: Q2 2025 in Review

Ameritas Investment Partners sold out of CAMP4 Therapeutics (CAMP) in Q2 2025, closing a stake of 720 shares — an estimated $2.88K sold.

Ameritas Investment Partners first reported a position in CAMP in Q4 2024 and held it in 2 quarters. The position peaked at $3.76K in Q4 2024. 29 funds tracked by Wall St. Rank hold CAMP as of Q2 2025.

  • Ameritas Investment Partners reported no remaining CAMP4 Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 720 CAMP4 Therapeutics shares in Q2 2025, an estimated $2.88K.
  • Ameritas Investment Partners first reported a position in CAMP4 Therapeutics in Q4 2024 and held it in 2 quarters.
  • Ameritas Investment Partners's CAMP4 Therapeutics position peaked at $3.76K in Q4 2024.
  • 29 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.